Skip to content
GLP-1 Scorecard
Menu
Graded #97

HealthSource

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

Visit HealthSourceWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$199/mo (all doses, compounded)
Tirzepatide
$299/mo (all doses, compounded)
Coverage
All 50 states
Brand-name
Compounded only

Weigh HealthSource against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because HealthSource dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value66/100
Dose & formulation83/100
Clinical oversight80/100
Labs & monitoring54/100
Fulfillment80/100
Contract terms55/100

Strengths

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

Where it loses points

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical

Bottom line — Grade C

Best for: Shoppers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.

Ranked #97 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest HealthSource — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect HealthSource's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on HealthSource's site. Not medical advice; see our disclosure.

← Back to the scorecard